Aducanumab debate: Expert views on Biogen's Alzheimer drug

There is some controversy surrounding Biogen's new Alzheimer's drug, aducanumab, which has received accelerated approval from the FDA. What is there to know about it?

from Medical and health information https://ift.tt/OGWjwAU
via IFTTT